ChiCTR2600119019 版本V1.0 版本创建时间2026/02/13 17:59:07 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600119019 

最近更新日期:

Date of Last Refreshed on:

2026-02-13 17:59:00 

注册时间:

Date of Registration:

2026-02-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

经颅光刺激对妇科腹腔镜手术患者术后睡眠障碍的影响

Public title:

Effect of Transcranial Photobiomodulation on Postoperative Sleep Disturbances in Patients Undergoing Gynecological Laparoscopic Surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经颅光刺激对妇科腹腔镜手术患者术后睡眠障碍的影响

Scientific title:

Effect of Transcranial Photobiomodulation on Postoperative Sleep Disturbances in Patients Undergoing Gynecological Laparoscopic Surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨建军 

研究负责人:

杨建军 

Applicant:

Yang Jianjun 

Study leader:

Yang Jianjun 

申请注册联系人电话:

Applicant telephone:

+86 13837160267

研究负责人电话:

Study leader's telephone:

+86 371 66862025

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

fccxueq@zzu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

jianjunyang1971@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省郑州市二七区建设东路 1 号

研究负责人通讯地址:

河南省郑州市二七区建设东路 1 号

Applicant address:

No. 1, Jianshe East Road, Erqi District, Zhengzhou City, Henan Province

Study leader's address:

No. 1, Jianshe East Road, Erqi District, Zhengzhou City, Henan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

郑州大学第一附属医院

Applicant's institution:

The First Affiliated Hospital of Zhengzhou University

研究负责人所在单位:

郑州大学第一附属医院

Affiliation of the Leader:

The First Affiliated Hospital of Zhengzhou University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-KY-2237-002

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

郑州大学第一附属医院临床试验伦理委员会

Name of the ethic committee:

The Ethics Committee of Scientific Research and Clinical Trial The First Affiliated Hospital of Zhengzhou University

伦理委员会批准日期:

Date of approved by ethic committee:

2026-01-23 00:00:00

伦理委员会联系人:

闫贺磊

Contact Name of the ethic committee:

Yan Helei

伦理委员会联系地址:

河南省郑州市二七区建设东路 1 号

Contact Address of the ethic committee:

No. 1, Jianshe East Road, Erqi District, Zhengzhou City, Henan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 371 66295219

伦理委员会联系人邮箱:

Contact email of the ethic committee:

yhl5721@163.com

研究实施负责(组长)单位:

郑州大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Zhengzhou University

研究实施负责(组长)单位地址:

河南省郑州市二七区建设东路 1 号

Primary sponsor's address:

No. 1, Jianshe East Road, Erqi District, Zhengzhou City, Henan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南省

市(区县):

Country:

China

Province:

Henan

City:

单位(医院):

郑州大学第一附属医院

具体地址:

河南省郑州市二七区建设东路 1 号

Institution
hospital:

The First Affiliated Hospital of Zhengzhou University

Address:

No. 1, Jianshe East Road, Erqi District, Zhengzhou City, Henan Province

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-funded

Target disease:

Postoperative sleep disturbance

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

评价经颅光刺激对妇科腹腔镜手术患者术后睡眠障碍发生率的影响;  

Objectives of Study:

To evaluate the effect of transcranial photobiomodulation on the incidence of postoperative sleep disturbances in patients undergoing gynecological laparoscopic surgery.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.在开始试验相关活动之前,自愿签署知情同意书,充分了解本实验的目的和意义,并自愿遵守本试验流程; 2.拟择期在全身麻醉下行妇科腹腔镜手术且手术时间预计 1h~3h ; 3.年龄 18~65 岁; 4.美国麻醉医师协会(ASA)分级Ⅰ或Ⅱ级; 5.18kg/m^2 <= 体重指数(BMI)<= 30kg/m^2.

Inclusion criteria

1. Before starting trial-related activities, voluntarily sign the informed consent form, fully understand the purpose and significance of this experiment, and voluntarily comply with the trial procedures; 2. Planned elective gynecological laparoscopic surgery under general anesthesia with an expected duration of 1 to 3 hours; 3. Age 18 to 65 years; 4. American Society of Anesthesiologists (ASA) physical status classification I or II; 5. Body mass index (BMI) between 18 kg/m^2 and 30 kg/m^2.

排除标准:

1.匹斯堡睡眠质量指数(PSQI)>7 分; 2.术前患神经精神疾病(如抑郁症、帕金森、精神分裂症、癫痫等)或与睡眠相关的疾病(如阻塞性睡眠呼吸暂停综合征等); 3.脑部疾病史(如脑梗、脑出血、颅内占位、脑外伤等); 4.神经外科手术史; 5.认知或交流障碍; 6.长期服用镇静安眠药; 7.严重的肝肾功能障碍; 8.怀孕或哺乳期; 9.拒绝参加本研究; 10.研究者判断受试者不适合参加本临床试验的其他情况.

Exclusion criteria:

1. Pittsburgh Sleep Quality Index (PSQI) > 7 points; 2. Preoperative neurological or psychiatric disorders (such as depression, Parkinson's disease, schizophrenia, epilepsy, etc.) or sleep-related disorders (such as obstructive sleep apnea syndrome, etc.); 3. History of brain disease (such as cerebral infarction, cerebral hemorrhage, intracranial lesions, traumatic brain injury, etc.); 4. History of neurosurgery; 5. Cognitive or communication impairments; 6. Long-term use of sedative or hypnotic drugs; 7. Severe liver or kidney dysfunction; 8. Pregnancy or breastfeeding; 9. Refusal to participate in this study; 10. Other conditions judged by the researcher that make the subject unsuitable for participation in this clinical trial.

研究实施时间:

Study execute time:

From 2026-02-01 00:00:00 To 2027-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-03-01 00:00:00 To 2026-11-30 00:00:00  

干预措施:

Interventions:

组别:

经颅光刺激组

样本量:

90

Group:

Transcranial Light Stimulation Group

Sample size:

干预措施:

经颅光刺激

干预措施代码:

Intervention:

Transcranial Light Stimulation, tLS

Intervention code:

组别:

对照组

样本量:

90

Group:

Control group

Sample size:

干预措施:

假刺激

干预措施代码:

Intervention:

sham-tLS

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南省 

市(区县):

 

Country:

China 

Province:

Henan 

City:

 

单位(医院):

郑州大学第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Zhengzhou University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

医院焦虑抑郁量表

指标类型:

次要指标

Outcome:

Hospital Anxiety and Depression Scale

Type:

Secondary indicator

测量时间点:

术后 1 天、术后 2 天、术后 3 天、术后 7 天

测量方法:

Measure time point of outcome:

POD1,POD2,POD3,POD7

Measure method:

指标中文名:

苏醒时间

指标类型:

次要指标

Outcome:

waking time

Type:

Secondary indicator

测量时间点:

麻醉苏醒期

测量方法:

Measure time point of outcome:

Anesthesia recovery period

Measure method:

指标中文名:

不良反应

指标类型:

次要指标

Outcome:

Adverse event

Type:

Secondary indicator

测量时间点:

术后 1 天、术后 2 天、术后 3 天、术后 7 天

测量方法:

Measure time point of outcome:

POD1,POD2,POD3,POD7

Measure method:

指标中文名:

阿片类药物消耗量

指标类型:

次要指标

Outcome:

Opioid drug consumption

Type:

Secondary indicator

测量时间点:

术后 1 天、术后 2 天、术后 3 天

测量方法:

Measure time point of outcome:

POD1,POD2,POD3

Measure method:

指标中文名:

术后第2 晚、第 3 晚、第 7 晚睡眠障碍发生率

指标类型:

次要指标

Outcome:

Incidence of sleep disorder on the 2nd, 3rd and 7th night after operation

Type:

Secondary indicator

测量时间点:

术后 2 天、术后 3 天、术后 7 天

测量方法:

Measure time point of outcome:

POD2,POD3,POD7

Measure method:

指标中文名:

术后第一晚睡眠障碍发生率

指标类型:

主要指标

Outcome:

Incidence of sleep disorder on the first night after operation

Type:

Primary indicator

测量时间点:

术后 1 天

测量方法:

Measure time point of outcome:

POD1

Measure method:

指标中文名:

脑电图

指标类型:

次要指标

Outcome:

electroencephalogram

Type:

Secondary indicator

测量时间点:

术中

测量方法:

Measure time point of outcome:

Intraoperative

Measure method:

指标中文名:

疼痛评分

指标类型:

次要指标

Outcome:

Pain score

Type:

Secondary indicator

测量时间点:

术后 1 天、术后 2 天、术后 3 天

测量方法:

Measure time point of outcome:

POD1,POD2,POD3

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

统计人员使用计算机产生随机数字

Randomization Procedure (please state who generates the random number sequence and by what method):

Randomization: Computer-generated

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

对研究者和参试者设盲

Blinding:

Blinding for researchers and participants

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用病例报告表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

case record form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-02-13 17:59:00